EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Kirsten rat sarcoma viral oncogene (KRAS)-targeted therapy across cancer types: Context, resistance, and future directions

Yunxin Liu, Mengzhao Wang

Cancer Pathogenesis and Therapy · 2026-10

DOI: 10.1016/j.cpt.2026.10.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Pathogenesis and Therapy, 2026-10. Verfasst von Yunxin Liu und 1 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Liu, Y., & Wang, M. (2026). Kirsten rat sarcoma viral oncogene (KRAS)-targeted therapy across cancer types: Context, resistance, and future directions. Cancer Pathogenesis and Therapy. https://doi.org/10.1016/j.cpt.2026.10.003

Vancouver

Liu Y, Wang M. Kirsten rat sarcoma viral oncogene (KRAS)-targeted therapy across cancer types: Context, resistance, and future directions. Cancer Pathogenesis and Therapy. 2026. doi:10.1016/j.cpt.2026.10.003

BibTeX
@article{Liu2026,
  author = {Liu, Yunxin and Wang, Mengzhao},
  title = {Kirsten rat sarcoma viral oncogene (KRAS)-targeted therapy across cancer types: Context, resistance, and future directions},
  journal = {Cancer Pathogenesis and Therapy},
  year = {2026},
  doi = {10.1016/j.cpt.2026.10.003}
}
Kostenlos starten →